DIAGNOSTIC PREPARATIONS HUMAN THERAPEUTICS

Brand Owner (click to sort) Address Description
AKCEA THERAPEUTICS AKCEA THERAPEUTICS, INC. 9th Floor 22 Boston Wharf Road Boston MA 02210 diagnostic preparations and human therapeutics for raising HDL or the diagnosis and treatment of elevated triglycerides, pancreatitis, dyslipidemia, insulin resistance, metabolic syndrome, diabetes, familial chylomicronemia syndrome, elevated Lp(a), hypertension, inflammation, thrombosis, atherosclerosis, hypercholesterolemia, lipodystrophy, and other cardiovascular, cardiopulmonary, metabolic and inflammatory diseases and disorders;THERAPEUTICS;
GENOMERON ISIS PHARMACEUTICALS, INC. 1896 Rutherford Rd. Carlsbad CA 92008 diagnostic preparations and human therapeutics; namely, macromolecules and oligonucleotides for clinical medical use;
IONIS IONIS PHARMACEUTICALS, INC. 2850 Gazelle Court Carlsbad CA 92010 Diagnostic preparations and human therapeutics for medical use, namely, antisense oligonucleotides;Medical and scientific research services in the areas of medicines and pharmaceuticals for antisense therapy;
IONIS PHARMACEUTICALS IONIS PHARMACEUTICALS, INC. 2850 Gazelle Court Carlsbad CA 92010 Diagnostic preparations and human therapeutics for medical use, namely, antisense oligonucleotides;PHARMACEUTICALS;
ISIS PHARMACEUTICALS ISIS PHARMACEUTICALS, INC. 1896 Rutherford Rd. Carlsbad CA 92008 DIAGNOSTIC PREPARATIONS AND HUMAN THERAPEUTICS, NAMELY, ANTISENSE OLIGONUCLEOTIDES;PHARMACEUTICALS;
ISIS PHARMACEUTICALS ISIS PHARMACEUTICALS, INC. 1896 Rutherford Rd. Carlsbad CA 92008 DIAGNOSTIC PREPARATIONS AND HUMAN THERAPEUTICS, NAMELY, ANTISENSE OLIGONUCLEOTIDES;PHARMACEUTICALS;
ISIS PHARMACEUTICALS ISIS PHARMACEUTICALS, INC. 1896 Rutherford Rd. Carlsbad CA 92008 diagnostic preparations and human therapeutics, namely, antisense oligonucleotides;Color is not claimed as a feature of the mark.;PHARMACEUTICALS;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention relates to method for the ESR-spectroscopic detection of changes in the transport properties of albumin in an albumin-containing sample. Said method can be used in the medical, biological, biotechnological and veterinary praxis for diagnostic purposes and/or for monitoring physiological or pathological changes in the human or animal body or for the quality control of albumin-containing preparations, especially blood products. The invention further relates to an ESR spectrometer for carrying out the inventive method, which-being an automated ESR analyzer-allows for a simple and reliable handling required in modern clinical laboratories. The inventive ESR spectrometer integrates automatic device controls, signal registration and signal evaluation in combination with a computer program for the diagnostic analysis of the measured data.